A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: Metabolic effects and opthalmologic effects

Journal of Diabetes and its Complications

Volumn 10, Issue 2, 1996, Pages 94-99

  Skowsky, W Ronald ^a   Siddiqui, Tariq ^b   Hodgetts, David ^b   Lambrou Jr , Fred H ^a   Stewart, Michael W ^a   Foster Jr , Malcolm T ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b H ^*

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; RECOMBINANT ALPHA2A INTERFERON; SOMATOMEDIN C;

ADULT; ARTICLE; CARBOHYDRATE TOLERANCE; CASE REPORT; CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; GONIOSCOPY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MATURITY ONSET DIABETES MELLITUS; MICROALBUMINURIA; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA HEMORRHAGE; SLIT LAMP; SUBCUTANEOUS DRUG ADMINISTRATION; VISUAL ACUITY;

EID: 0029964660     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00005-4     Document Type: Article

References (21)

1. Rand L: Recent Advances in diabetic retinopathy. Am J Med 70:595-601, 1981.
2. Klein R, Klein B, Moss S, Davis M, DeMet SD: The Wisconsin epidemiologic study of diabetes retinopathy: Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984.
3. Klein R, Klein B, Moss S, Davis M, De Met SD: The Wisconsin epidemiologic study of diabetic retinopathy: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532, 1984.
4. Klein R, Klein B, Moss S, Davis M, De Met SD: The Wisconsin epidemiologic study of diabetic retinopathy: Diabetic macular edema. Arch Ophthalmol 102:1464-1474, 1984.
5. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy: ETDRS Report Number 9. Ophthalmology 98(suppl): 766-785, 1991.
6. Folkman J: Successful treatment of an angiogenic disease. [Editorial]. N Engl J Med 320:1211-1212, 1989.
7. Taylor CM, Weiss JB: Raised endothelial cell stimulating angiogenic factor in diabetic retinopathy. Lancet 2: 1329, 1989.
8. Folkman J, Klagsburn M: Angiogenic factors. Science 235:442-447, 1987.
9. Tsuruoka N, Sugiyama M, Tawaragy Y, Tsujimoto M, Nishihara T, Goto T, Sato N: Inhibition of in vitro angiogenesis by lymphotoxin on interferon gamma. Biochem Biophys Res Commun 155:429-435, 1988.
10. Speigel RJ: The alpha interferons: Clinical overview. Semin Oncol 14 (suppl 2):1-12, 1989.
11. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL: Treatment of pulmonary hemangiomatosis with recombinant interferon alfa 2. N Engl J Med 30: 1197-1200, 1989.
12. Volvista V, Pelkonen R, Cantell K: Effects of interferon on glucose tolerance and insulin sensitivity. Diabetes 38:641-647, 1989.
13. Michaelson IC: The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophth Soc UK 68:137-180, 1948.
14. Petty RG, Pearson JD, Morgan DM, Mahler RF: Stimulation of endothelial cell growth by sera from diabetic patients with retinopathy. Lancet 1:208-211, 1988.
15. Friesel R, Komariya A, Maciag T: Inhibition of endothelial cell proliferation by gamma interferon. J Cell Biol 104:689-696, 1987.
16. Sidky Y, Borden E: Inhibition of angiogenesis by interferon: effects on tumor and lymphocyte induced responses. Cancer Res 47:5155-5161, 1987.
17. Stinson WG, Miller JW, Puliafito CA, Folkman J: Alpha-interferon treatment of experimental iris neovascularization. Invest Ophthalmol Vis Sci 98(suppl): 123, 1991.
18. Fung WE: [Letter] Interferon alpha 2a treatment for age-related macular degeneration. Am J Ophthalmol 112: 349-350, 1991.
19. Ezekowitz RA, Mulliken JB, Folkman J: Interferon alpha 2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456-1463, 1992.
20. Foulis AK, Farquharson MA, Meager A: Immunoreactive interferon in insulin-secreting β cells in type I diabetes mellitus. Lancet 2:1423-1427, 1987.
21. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JJ, Parke D, Kelley J, Tang RA, Marmor M, Abrams G, Miller JW, Gragoudas ES: Interferon-associated retinopathy. Arch Ophthalmol 111:350-356, 1993.